miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44

Introduction: Metastasis and drug resistance contribute substantially to the poor prognosis of colorectal cancer (CRC) patients. However, the epigenetic regulatory mechanisms by which CRC develops metastatic and drug-resistant characteristics remain unclear. This study aimed to investigate the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lina, Fang, Ying, Wang, Xin, Han, Yanan, Du, Feng, Li, Cunxi, Hu, Huaying, Liu, Hao, Liu, Qi, Wang, Jing, Liang, Junrong, Chen, Ping, Yang, Hongbin, Nie, Yongzhan, Wu, Kaichun, Fan, Daiming, Coffey, Robert J., Lu, Yuanyuan, Zhao, Xiaodi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857048/
https://www.ncbi.nlm.nih.gov/pubmed/31754405
http://dx.doi.org/10.7150/thno.36605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857048/
https://www.ncbi.nlm.nih.gov/pubmed/31754405
http://dx.doi.org/10.7150/thno.36605

Ejemplares similares